Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.7200
-0.0677 (-8.59%)
At close: Jul 15, 2025, 4:00 PM
0.7399
+0.0199 (2.76%)
After-hours: Jul 15, 2025, 6:54 PM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $90.83 million as of July 15, 2025. Its market cap has decreased by -67.34% in one year.
Market Cap
90.83M
Enterprise Value
-18.64M
1-Year Change
-67.34%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has decreased from $117.04M to $90.83M, a decrease of -22.39%. That is a compound annual growth rate of -5.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 99.37M | -52.89% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.60B |
| Johnson & Johnson | 377.32B |
| AbbVie | 338.30B |
| Novo Nordisk | 308.09B |
| UnitedHealth Group | 272.67B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 229.71B |
| AstraZeneca | 222.35B |